Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MethMax
NCT06649136Phase 4Recruiting
- Sponsor
- Medical University of Vienna
- Start
- Aug 2024
- Primary completion
- Jun 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methotrexate in rheumatoid arthritis (RA), sponsored by Medical University of Vienna. Started Aug 2024; status: recruiting.
02
Drugs
methotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT06649136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06649136.